Neonatal & Pediatric Oncology
Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are leukemia (begins in blood-forming tissue such as bone marrow), lymphoma (cancer in the cells of immune system), neuroblastoma (nerve cells), retinoblastoma (occurs in the tissues of the retina), Wilms tumor (kidney cancer), and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.
- Pediatric Cardiology
- Pediatric Surgery
- Vaccinology
Related Conference of Neonatal & Pediatric Oncology
November 24-25, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Barcelona, Spain
November 24-25, 2025
47th Euro-Global Summit on Cancer Therapy & Radiation Oncology
Barcelona, Spain
Neonatal & Pediatric Oncology Conference Speakers
Recommended Sessions
- Pediatric Dermatology
- Clinical Neonatology
- Clinical Pediatrics
- Neonatal & Pediatric Endocrinology
- Neonatal & Pediatric Hematology
- Neonatal & Pediatric Imaging
- Neonatal & Pediatric Immunology
- Neonatal & Pediatric leukemia
- Neonatal & Pediatric Nutrition
- Neonatal & Pediatric Oncology
- Neonatal & Pediatric Oncology Diagnosis
- Neonatal & Pediatric Pulmonology
- Neonatal & Pediatric Radiology
- Neonatology & Pediatrics
- Neuroblastoma
- Palliative care for Cancer
- Pediatric Neuro Oncology
- Pediatric Oncology Nursing
- Therapies in Neonatal & Pediatric Oncology
Related Journals
Are you interested in
- Advancements in Oncology Nursing: Trends and Best Practicss - World Cancer 2025 (Switzerland)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Cancer Research and Treatment - Cancer Drugs 2025 (France)
- AI and Machine Learning in Cancer Care - CANCER2025 (Netherlands)
- Alternative Treatment and Cancer Therapy - Cancer Research 2025 (Spain)
- Alternative Treatments and Therapeutics - Cancer Science 2025 (France)
- Anti-Cancer Drug Discovery and Development - Cancer Research 2025 (Spain)
- Anti-Cancer Drug Discovery and Development - Cancer Drugs 2025 (France)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence in Cancer Research - CANCER BIOLOGY- 2025 (Italy)
- Biomarkers and Liquid Biopsy - CANCER BIOLOGY- 2025 (Italy)
- Breast Cancer - Cancer Meeting Summit 2025 (France)
- Breast Cancer - Euro Cancer 2025 (Spain)
- Breast Cancer - Cancer Science 2025 (France)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer: Screening, Diagnosis, and Treatment - CANCER2025 (Netherlands)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Cancer & Stem Cell Therapy - Cancer Meeting Summit 2025 (France)
- Cancer & Stem Cell Therapy - Euro Cancer 2025 (Spain)
- Cancer and its Relevance with other Diseases - Cancer Drugs 2025 (France)
- Cancer Awareness and Survival - Cancer Meeting Summit 2025 (France)
- Cancer Awareness and Survival - World Cancer-2025 (Spain)
- Cancer Biology - CANCER BIOLOGY- 2025 (Italy)
- Cancer Biology and Drug Delivery - Cancer Research 2025 (Spain)
- Cancer Biomarkers - Cancer Meeting Summit 2025 (France)
- Cancer Biomarkers & Bioinformatics - Cancer Drugs 2025 (France)
- Cancer Biopsy - Cancer Meeting Summit 2025 (France)
- Cancer Causes & Risk Factors - Cancer Drugs 2025 (France)
- Cancer Causes and Risk Factors - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Geneti - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Genetics - World Cancer-2025 (Spain)
- Cancer Clinical Trials - Cancer Research 2025 (Spain)
- Cancer Control and Prevention - Cancer Science 2025 (France)
- Cancer Control and Survivorship Care - CANCER BIOLOGY- 2025 (Italy)
- Cancer Diagnosis - Euro Cancer 2025 (Spain)
- Cancer Diagnostics - World Cancer 2025 (Switzerland)
- Cancer Drugs - Euro Cancer 2025 (Spain)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2025 (France)
- Cancer Epidemiology - World Cancer-2025 (Spain)
- Cancer Epidemiology - Cancer Drugs 2025 (France)
- Cancer Epidemiology and Public Health - World Cancer 2025 (Switzerland)
- Cancer Epidemiology and Public Health - CANCER BIOLOGY- 2025 (Italy)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Cancer Research 2025 (Spain)
- Cancer Epigenetics - Cancer Science 2025 (France)
- Cancer Genetics and Epigenetics - Cancer Research 2025 (Spain)
- Cancer Genomics and Epigenetics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Immunology & Immunotherapy - Euro Cancer 2025 (Spain)
- Cancer Immunology & Immunotherapy - World Cancer-2025 (Spain)
- Cancer Immunology & Immunotherapy - Cancer Drugs 2025 (France)
- Cancer Immunology and Immunotherapy - World Cancer 2025 (Switzerland)
- Cancer Immunology and Immunotherapy - CANCER BIOLOGY- 2025 (Italy)
- Cancer immunotherapy: Car T Cell Technology - Cancer Research 2025 (Spain)
- Cancer Metabolism and Nutritional Interventions - CANCER2025 (Netherlands)
- Cancer Metastasis - Cancer Science 2025 (France)
- Cancer Nanotechnology - World Cancer-2025 (Spain)
- Cancer Nanotechnology - Cancer Drugs 2025 (France)
- Cancer Pathology & Genetics - Cancer Drugs 2025 (France)
- Cancer Personalized Medicine - Euro Cancer 2025 (Spain)
- Cancer Pharma Industry - Cancer Research 2025 (Spain)
- Cancer Pharmacology - World Cancer-2025 (Spain)
- Cancer Pharmacology - Cancer Drugs 2025 (France)
- Cancer Pharmacology and Drug Development - CANCER BIOLOGY- 2025 (Italy)
- Cancer Prevention - Euro Cancer 2025 (Spain)
- Cancer Prevention & Research - Cancer Meeting Summit 2025 (France)
- Cancer Prevention and Early Detection: The Nurse’s Role - World Cancer 2025 (Switzerland)
- Cancer Prevention and Risk Reduction - CANCER2025 (Netherlands)
- Cancer Prevention Vaccines - Cancer Drugs 2025 (France)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Cancer Research 2025 (Spain)
- Cancer Research - Euro Cancer 2025 (Spain)
- Cancer Science - Cancer Science 2025 (France)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2025 (France)
- Cancer Stem Cells and Therapeutics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Stem Cells and Therapeutics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Stem Cells and Tumor Biology - CANCER2025 (Netherlands)
- Cancer Treatment and Therapeutics - World Cancer 2025 (Switzerland)
- Cancer Vaccines - Cancer Meeting Summit 2025 (France)
- Cancer Vaccines and Preventive Strategies - CANCER BIOLOGY- 2025 (Italy)
- Cancer Vaccinology and Preventive Vaccines - CANCER2025 (Netherlands)
- Cancer: Psychological & Social factors - World Cancer-2025 (Spain)
- Cancers & Stem Cell therapy - World Cancer-2025 (Spain)
- Cancers Biomarkers - Cancer Science 2025 (France)
- Cancers Biomarkers - World Cancer-2025 (Spain)
- Cancers Biopsy - World Cancer-2025 (Spain)
- Cancers Chemotherapy - World Cancer-2025 (Spain)
- Cancers Metabolomics - World Cancer-2025 (Spain)
- Cancers Metastasis - World Cancer-2025 (Spain)
- Cancers Pharmacology - Cancer Science 2025 (France)
- Cancers Prevention & Research - World Cancer-2025 (Spain)
- Cancers Therapy & Treatments - World Cancer-2025 (Spain)
- Cancers Vaccines - World Cancer-2025 (Spain)
- Cancers: lifestyle Connection and Nutrition - World Cancer-2025 (Spain)
- CAR-T Cell Therapy and Cell-Based Treatments - CANCER2025 (Netherlands)
- Cell and Gene Therapy for Cancer - Cancer Research 2025 (Spain)
- Circulating Tumor Cell (CTC) - Cancer Research 2025 (Spain)
- Clinical and Medical Case Reports - Cancer Drugs 2025 (France)
- Clinical Trials and Regulatory Aspects in Oncology - CANCER2025 (Netherlands)
- Clinical Trials and Research Innovations - World Cancer 2025 (Switzerland)
- Complementary & Alternate Methods and Cancer - World Cancer-2025 (Spain)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Spain)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Spain)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Spain)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Spain)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Spain)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Spain)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Spain)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Spain)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Spain)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Spain)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Spain)
- DNA Damage and Mutation - Cancer Drugs 2025 (France)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2025 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Spain)
- Early Detection and Prevention - World Cancer 2025 (Switzerland)
- Early Detection and Screening Innovations - CANCER2025 (Netherlands)
- Emerging Technologies in Cancer Research - World Cancer 2025 (Switzerland)
- Environmental Carcinogens and Cancer Epidemiology - CANCER2025 (Netherlands)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Spain)
- Gene Editing & CRISPR in Cancer - World Cancer-2025 (Spain)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Genomics and Cancer Epigenetics - CANCER2025 (Netherlands)
- Gynaecological Cancers - Cancer Meeting Summit 2025 (France)
- Hematology- Oncology - Cancer Science 2025 (France)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Immunotherapy and Cancer Vaccines - CANCER2025 (Netherlands)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Spain)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Spain)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Research - CANCER BIOLOGY- 2025 (Italy)
- Liquid Biopsy and Non-Invasive Diagnostics - CANCER2025 (Netherlands)
- Managing Cancer Care & Patient Support - Cancer Drugs 2025 (France)
- MicroRNA and Cancer - Cancer Drugs 2025 (France)
- Molecular Biology of Cancer - World Cancer 2025 (Switzerland)
- Molecular Biology of Cancer - CANCER BIOLOGY- 2025 (Italy)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Spain)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Nanotechnology in Cancer Treatment - Cancer Research 2025 (Spain)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2025 (France)
- Neonatal & Pediatric Oncology - World Cancer-2025 (Spain)
- Neurological Cancers & Brain Tumors - Cancer Meeting Summit 2025 (France)
- Novel Approaches to Cancer Treatment - Cancer Research 2025 (Spain)
- Nursing Leadership and Professional Development in Oncology - World Cancer 2025 (Switzerland)
- Oncogenomics - Cancer Science 2025 (France)
- Oncologic Imaging and Diagnostics - CANCER BIOLOGY- 2025 (Italy)
- Oncology - Euro Cancer 2025 (Spain)
- Oncology Nursing and Care - Cancer Science 2025 (France)
- Oncology Nursing and Care - World Cancer-2025 (Spain)
- Oncology Nursing and Patient Care - CANCER2025 (Netherlands)
- Oncology Nursing Care - Cancer Meeting Summit 2025 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2025 (France)
- Oncolytic Virus and Cancer - Cancer Meeting Summit 2025 (France)
- Organ Specific Cancer - Cancer Meeting Summit 2025 (France)
- Organ Specific Cancer - Cancer Research 2025 (Spain)
- Organ-defined Cancers - World Cancer-2025 (Spain)
- Organic Specific Cancer - Cancer Science 2025 (France)
- Palliative Care and Quality of Life - CANCER2025 (Netherlands)
- Pediatric Oncology - World Cancer 2025 (Switzerland)
- Pediatric Oncology - CANCER BIOLOGY- 2025 (Italy)
- Pediatric Oncology - Cancer Drugs 2025 (France)
- Pediatric Oncology Innovations - CANCER2025 (Netherlands)
- Pharmacovigilance and Drug Safety in Oncology - CANCER2025 (Netherlands)
- Precision Cancers Medicinal Drug & Oncology - World Cancer-2025 (Spain)
- Precision Medicine and Immuno-Oncology - Cancer Research 2025 (Spain)
- Precision Oncology and Personalized Medicine - CANCER2025 (Netherlands)
- Psychosocial Oncology and Mental Health - CANCER2025 (Netherlands)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Radiation Oncology - Euro Cancer 2025 (Spain)
- Radiation Oncology and Radiotherapy Advances - CANCER2025 (Netherlands)
- Radiation Therapy - CANCER BIOLOGY- 2025 (Italy)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiology & Imaging in Cancer Diagnosis & Therapy - Cancer Research 2025 (Spain)
- Radiology & Imaging Technologies - Cancer Drugs 2025 (France)
- Rare Cancers and Orphan Drugs - CANCER2025 (Netherlands)
- Regenerative Medicines - Cancer Drugs 2025 (France)
- Robotic Oncology - Cancer Drugs 2025 (France)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Spain)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Spain)
- Skin Cancer - Cancer Science 2025 (France)
- Supportive Care and Palliative Medicine - World Cancer 2025 (Switzerland)
- Surgical & Clinical Oncology - Cancer Drugs 2025 (France)
- Surgical and Clinical Oncology - Cancer Meeting Summit 2025 (France)
- Surgical Oncology and Minimally Invasive Techniques - CANCER2025 (Netherlands)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Targeted Cancer Therapy - Cancer Research 2025 (Spain)
- Targeted Therapy and Molecular Diagnostics - CANCER2025 (Netherlands)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Spain)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Spain)
- Telemedicine and Digital Health in Oncology - CANCER2025 (Netherlands)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Spain)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Tumor Biology - Cancer Science 2025 (France)
- Tumor Microenvironment - CANCER BIOLOGY- 2025 (Italy)
- Tumor Microenvironment and Metastasis - CANCER2025 (Netherlands)
- Tumor Virology - Cancer Science 2025 (France)
- Tumor Virology, Immunology & Mobile Pathology - World Cancer-2025 (Spain)
- Tumour Virology, Immunology & Cellular Pathology - Cancer Meeting Summit 2025 (France)
- Types of Cancer - Euro Cancer 2025 (Spain)